PURPOSE: To evaluate optical coherence tomography (OCT) retinal nerve fiber layer thickness (RNFLT) measurement for glaucoma progression analysis. METHODS: One hundred sixteen eyes of 64 patients with glaucoma who were observed within a period of 5 years were included. All eyes had at least four serial RNFL measurements obtained with the Stratus OCT (Carl Zeiss Meditec, Dublin, CA) and with the first and last measurements separated by at least 3 years. Visual field (VF) testing was performed on the same day as RNFL imaging. Serial average RNFLTs were evaluated with guided progression analysis (GPA). VF progression was assessed with trend analysis of the visual field index (VFI). Factors associated with the rate of change in RNFLT were examined with a linear mixed model. RESULTS: A total of 1101 OCT scans and 1029 VFs were analyzed. Twenty-one and 22 eyes had progression according to RNFL and VF measurements, respectively, and 3 eyes had progression according to both measurements. The rate of change in VFI and RNFLT ranged between -0.5% and -7.2% per year (median loss, -3.0%/y) and between -1.2 and -15.4 microm per year (median loss, -3.3 microm/y), respectively. The sector at seven o'clock (right eye orientation) was the most frequent location that showed progression. A greater baseline RNFLT was associated with an increased rate of reduction of RNFLT (P = 0.034). CONCLUSIONS: OCT GPA offers a new approach to augment glaucoma progression analysis. The rate of RNFLT thinning was variable among patients with glaucoma, with an increased rate of loss in patients with a higher baseline RNFLT.
PURPOSE: To evaluate optical coherence tomography (OCT) retinal nerve fiber layer thickness (RNFLT) measurement for glaucoma progression analysis. METHODS: One hundred sixteen eyes of 64 patients with glaucoma who were observed within a period of 5 years were included. All eyes had at least four serial RNFL measurements obtained with the Stratus OCT (Carl Zeiss Meditec, Dublin, CA) and with the first and last measurements separated by at least 3 years. Visual field (VF) testing was performed on the same day as RNFL imaging. Serial average RNFLTs were evaluated with guided progression analysis (GPA). VF progression was assessed with trend analysis of the visual field index (VFI). Factors associated with the rate of change in RNFLT were examined with a linear mixed model. RESULTS: A total of 1101 OCT scans and 1029 VFs were analyzed. Twenty-one and 22 eyes had progression according to RNFL and VF measurements, respectively, and 3 eyes had progression according to both measurements. The rate of change in VFI and RNFLT ranged between -0.5% and -7.2% per year (median loss, -3.0%/y) and between -1.2 and -15.4 microm per year (median loss, -3.3 microm/y), respectively. The sector at seven o'clock (right eye orientation) was the most frequent location that showed progression. A greater baseline RNFLT was associated with an increased rate of reduction of RNFLT (P = 0.034). CONCLUSIONS: OCT GPA offers a new approach to augment glaucoma progression analysis. The rate of RNFLT thinning was variable among patients with glaucoma, with an increased rate of loss in patients with a higher baseline RNFLT.
Authors: Kyung Rim Sung; Jong S Kim; Gadi Wollstein; Lindsey Folio; Michael S Kook; Joel S Schuman Journal: Br J Ophthalmol Date: 2010-10-28 Impact factor: 4.638
Authors: Vittorio Porciatti; William J Feuer; Pedro Monsalve; Giacinto Triolo; Luis Vazquez; John McSoley; Lori M Ventura Journal: J Glaucoma Date: 2017-05 Impact factor: 2.503
Authors: Abinaya Thenappan; Carlos Gustavo De Moraes; Diane L Wang; Daiyan Xin; Ravivarn Jarukasetphon; Robert Ritch; Donald C Hood Journal: J Glaucoma Date: 2017-05 Impact factor: 2.503
Authors: Felipe A Medeiros; Linda M Zangwill; Christopher A Girkin; Jeffrey M Liebmann; Robert N Weinreb Journal: Am J Ophthalmol Date: 2012-02-07 Impact factor: 5.258
Authors: Felipe A Medeiros; Linda M Zangwill; Douglas R Anderson; Jeffrey M Liebmann; Christopher A Girkin; Ronald S Harwerth; Marie-Josée Fredette; Robert N Weinreb Journal: Am J Ophthalmol Date: 2012-07-27 Impact factor: 5.258
Authors: Felipe A Medeiros; Renato Lisboa; Robert N Weinreb; Jeffrey M Liebmann; Christopher Girkin; Linda M Zangwill Journal: Ophthalmology Date: 2012-12-12 Impact factor: 12.079